Unlock First-Line Glaucoma Care with DSLT
DSLT is designed to automatically deliver 120 laser pulses directly through the limbus to the trabecular meshwork to improve aqueous outflow and reduce intraocular pressure.
Evolving First-Line Treatment Paradigm
The Laser in Glaucoma and Ocular Hypertension (LiGHT) study found that SLT is efficacious as a primary procedure for the treatment of OAG and OHT.1
Recognizes SLT as an effective primary intervention for OAG2
Recommends that SLT should be considered as an initial treatment option for mild or moderate OAG and OHT patients3
Recommends 360o SLT as first-line treatment for people with newly diagnosed OHT and COAG4
Exceptional Experience for the Patient and Physician
“Using the DSLT is awesome. It’s really a step ahead - not only for the comfort of the patient, but also efficiency.”
Univ. -Prof. Dr. med. Burkhard Dick Bochum University Eye Hospital
Introducing DSLT
Effective IOP-Lowering with a Proven Safety Profile
Direct Selective Laser Trabeculoplasty (DSLT) in Open Angle Glaucoma (OAG)
and Ocular Hypertension (OHT): A Randomized Controlled Trial (GLAUrious)5
Decreased Medication Burden
At 12 months5:
62%
of all DSLT patients were medication-free
70%
of DSLT patients who entered the study medication-free, remained medication-free
81%
of DSLT patients were on the same or fewer medications
Proven Safety Profile with Low Rate of Ocular Adverse Events
In DSLT group5:
0
No serious AEs as a result of the procedure through 12 months
1.0%
Extremely low rate of SSIs for IOP control at 12 months
6.1%
Low rate of non-serious AEs at >6 months
DSLT Resources
2022 Journal of Glaucoma
Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Radcliffe N, et al.
2021 TVST – ARVO Journal
Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial
Goldenfeld M, et al.
2021 British Journal of Ophthalmology
Direct selective laser trabeculoplasty in open angle glaucoma study design
Congdon N, et al.
REFERENCES:
1. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology. 2023;130(2):139-151.
2. Takusagawa HL, Hoguet A, Sit AJ, et al. Selective laser trabeculoplasty for the treatment of glaucoma. Ophthalmology. 2024;131(1):37-47. doi:10.1016/j.ophtha.2023.07.029.
3. European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105(Suppl 1):1-169. doi:10.1136/bjophthalmol-2021-egsguidelines.
4. National Institute for Health and Care Excellence. Glaucoma: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2022.
5. GLAUrious Study - Clinical Study Report (CSR). CA-RP-01-006, Rev. 01; 2022.
Please refer to the relevant product direction for use for list of indications, contraindications and warnings.
